ADME–Enabling Technologies in Drug Design and Development
Autor D Zhangen Limba Engleză Hardback – 24 mai 2012
Preț: 1202.44 lei
Preț vechi: 1321.36 lei
-9% Nou
Puncte Express: 1804
Preț estimativ în valută:
230.09€ • 242.99$ • 191.48£
230.09€ • 242.99$ • 191.48£
Carte tipărită la comandă
Livrare economică 13-27 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780470542781
ISBN-10: 0470542780
Pagini: 622
Dimensiuni: 220 x 287 x 38 mm
Greutate: 1.62 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470542780
Pagini: 622
Dimensiuni: 220 x 287 x 38 mm
Greutate: 1.62 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Scientists in the pharmaceutical industry, medicine, pre–clinical drug discovery and development researchers, chemists and clinical researchers; academic drug metabolism experts; new industry recruits, toxicology, bioanalytical researchers.Notă biografică
Donglu Zhang, PhD, is a Principal Scientist in Pharmaceutical Candidate Optimization at Bristol-Myers Squibb in Princeton, New Jersey. He has published seventy peer-reviewed articles, codiscovered the Mass Defect Filtering technique, and coedited two books. Sekhar Surapaneni, PhD, is Director, DMPK, at Celgene Corporation in New Jersey. He has published extensively in peer-reviewed journals and is a member of ISSX and ACS.
Descriere
This book comprehensively covers the state-of-the-art and cutting-edge technologies in an integrated fashion for applications in ADME studies of small molecular drugs. Each chapter provides descriptions of the technologies, application scope and limitations, optimal conditions for intended results, protocols, case studies, and future developments.